Highly specific prototype test detects the virus spike protein at clinically relevant concentrations
Highly specific prototype test detects the virus spike protein at clinically relevant concentrations
Catenae Innovation PLC (AIM: CTEA), the AIM-quoted provider of digital media and technology, reports that, further to the announcement of 17 April 2020, the Company has built an operational prototype